Table of Content

1 Report Overview
1.1 Oral Anticoagulants Definition
1.2 Market by Type
1.2.1 Global Oral Anticoagulants Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Direct Thrombin Inhibitors
1.2.3 Direct Factor Xa Inhibitors
1.3 Market Segment by Application
1.3.1 Global Oral Anticoagulants Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Deep Vein Thrombosis (DVT)
1.3.3 Pulmonary Embolism
1.3.4 Acute Coronary Syndrome
1.3.5 Hemodialysis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Oral Anticoagulants Sales
2.1 Global Oral Anticoagulants Revenue Estimates and Forecasts 2018-2034
2.2 Global Oral Anticoagulants Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Oral Anticoagulants Revenue by Region
2.3.1 Global Oral Anticoagulants Revenue by Region (2018-2023)
2.3.2 Global Oral Anticoagulants Revenue by Region (2024-2034)
2.4 Global Oral Anticoagulants Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Oral Anticoagulants Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Oral Anticoagulants Sales Quantity by Region
2.6.1 Global Oral Anticoagulants Sales Quantity by Region (2018-2023)
2.6.2 Global Oral Anticoagulants Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Oral Anticoagulants Sales Quantity by Manufacturers
3.1.1 Global Oral Anticoagulants Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Oral Anticoagulants Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Oral Anticoagulants Sales in 2024
3.2 Global Oral Anticoagulants Revenue by Manufacturers
3.2.1 Global Oral Anticoagulants Revenue by Manufacturers (2018-2023)
3.2.2 Global Oral Anticoagulants Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Oral Anticoagulants Revenue in 2024
3.3 Global Oral Anticoagulants Sales Price by Manufacturers
3.4 Global Key Players of Oral Anticoagulants, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oral Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oral Anticoagulants, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oral Anticoagulants, Product Offered and Application
3.8 Global Key Manufacturers of Oral Anticoagulants, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Oral Anticoagulants Sales Quantity by Type
4.1.1 Global Oral Anticoagulants Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Oral Anticoagulants Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Oral Anticoagulants Sales Quantity Market Share by Type (2018-2034)
4.2 Global Oral Anticoagulants Revenue by Type
4.2.1 Global Oral Anticoagulants Historical Revenue by Type (2018-2023)
4.2.2 Global Oral Anticoagulants Forecasted Revenue by Type (2024-2034)
4.2.3 Global Oral Anticoagulants Revenue Market Share by Type (2018-2034)
4.3 Global Oral Anticoagulants Price by Type
4.3.1 Global Oral Anticoagulants Price by Type (2018-2023)
4.3.2 Global Oral Anticoagulants Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Oral Anticoagulants Sales Quantity by Application
5.1.1 Global Oral Anticoagulants Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Oral Anticoagulants Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Oral Anticoagulants Sales Quantity Market Share by Application (2018-2034)
5.2 Global Oral Anticoagulants Revenue by Application
5.2.1 Global Oral Anticoagulants Historical Revenue by Application (2018-2023)
5.2.2 Global Oral Anticoagulants Forecasted Revenue by Application (2024-2034)
5.2.3 Global Oral Anticoagulants Revenue Market Share by Application (2018-2034)
5.3 Global Oral Anticoagulants Price by Application
5.3.1 Global Oral Anticoagulants Price by Application (2018-2023)
5.3.2 Global Oral Anticoagulants Price Forecast by Application (2024-2034)
6 North America
6.1 North America Oral Anticoagulants Sales by Company
6.1.1 North America Oral Anticoagulants Revenue by Company (2018-2023)
6.1.2 North America Oral Anticoagulants Sales Quantity by Company (2018-2023)
6.2 North America Oral Anticoagulants Market Size by Type
6.2.1 North America Oral Anticoagulants Sales Quantity by Type (2018-2034)
6.2.2 North America Oral Anticoagulants Revenue by Type (2018-2034)
6.3 North America Oral Anticoagulants Market Size by Application
6.3.1 North America Oral Anticoagulants Sales Quantity by Application (2018-2034)
6.3.2 North America Oral Anticoagulants Revenue by Application (2018-2034)
6.4 North America Oral Anticoagulants Market Size by Country
6.4.1 North America Oral Anticoagulants Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Oral Anticoagulants Revenue by Country (2018-2034)
6.4.3 North America Oral Anticoagulants Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Oral Anticoagulants Sales by Company
7.1.1 Europe Oral Anticoagulants Sales Quantity by Company (2018-2023)
7.1.2 Europe Oral Anticoagulants Revenue by Company (2018-2023)
7.2 Europe Oral Anticoagulants Market Size by Type
7.2.1 Europe Oral Anticoagulants Sales Quantity by Type (2018-2034)
7.2.2 Europe Oral Anticoagulants Revenue by Type (2018-2034)
7.3 Europe Oral Anticoagulants Market Size by Application
7.3.1 Europe Oral Anticoagulants Sales Quantity by Application (2018-2034)
7.3.2 Europe Oral Anticoagulants Revenue by Application (2018-2034)
7.4 Europe Oral Anticoagulants Market Size by Country
7.4.1 Europe Oral Anticoagulants Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Oral Anticoagulants Revenue by Country (2018-2034)
7.4.3 Europe Oral Anticoagulants Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Oral Anticoagulants Sales by Company
8.1.1 China Oral Anticoagulants Sales Quantity by Company (2018-2023)
8.1.2 China Oral Anticoagulants Revenue by Company (2018-2023)
8.2 China Oral Anticoagulants Market Size by Type
8.2.1 China Oral Anticoagulants Sales Quantity by Type (2018-2034)
8.2.2 China Oral Anticoagulants Revenue by Type (2018-2034)
8.3 China Oral Anticoagulants Market Size by Application
8.3.1 China Oral Anticoagulants Sales Quantity by Application (2018-2034)
8.3.2 China Oral Anticoagulants Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Oral Anticoagulants Sales by Company
9.1.1 APAC Oral Anticoagulants Sales Quantity by Company (2018-2023)
9.1.2 APAC Oral Anticoagulants Revenue by Company (2018-2023)
9.2 APAC Oral Anticoagulants Market Size by Type
9.2.1 APAC Oral Anticoagulants Sales Quantity by Type (2018-2034)
9.2.2 APAC Oral Anticoagulants Revenue by Type (2018-2034)
9.3 APAC Oral Anticoagulants Market Size by Application
9.3.1 APAC Oral Anticoagulants Sales Quantity by Application (2018-2034)
9.3.2 APAC Oral Anticoagulants Revenue by Application (2018-2034)
9.4 APAC Oral Anticoagulants Market Size by Region
9.4.1 APAC Oral Anticoagulants Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Oral Anticoagulants Revenue by Region (2018-2034)
9.4.3 APAC Oral Anticoagulants Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oral Anticoagulants Sales by Company
10.1.1 Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Oral Anticoagulants Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Oral Anticoagulants Market Size by Type
10.2.1 Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Oral Anticoagulants Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Oral Anticoagulants Market Size by Application
10.3.1 Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Oral Anticoagulants Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Oral Anticoagulants Market Size by Country
10.4.1 Middle East, Africa and Latin America Oral Anticoagulants Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Oral Anticoagulants Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Johnson & Johnson Oral Anticoagulants Products and Services
11.1.5 Johnson & Johnson Oral Anticoagulants SWOT Analysis
11.1.6 Johnson & Johnson Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Information
11.2.2 Bristol-Myers Squibb Overview
11.2.3 Bristol-Myers Squibb Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Bristol-Myers Squibb Oral Anticoagulants Products and Services
11.2.5 Bristol-Myers Squibb Oral Anticoagulants SWOT Analysis
11.2.6 Bristol-Myers Squibb Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Boehringer Ingelheim Oral Anticoagulants Products and Services
11.3.5 Boehringer Ingelheim Oral Anticoagulants SWOT Analysis
11.3.6 Boehringer Ingelheim Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Sanofi Oral Anticoagulants Products and Services
11.4.5 Sanofi Oral Anticoagulants SWOT Analysis
11.4.6 Sanofi Recent Developments
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Information
11.5.2 Daiichi Sankyo Overview
11.5.3 Daiichi Sankyo Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Daiichi Sankyo Oral Anticoagulants Products and Services
11.5.5 Daiichi Sankyo Oral Anticoagulants SWOT Analysis
11.5.6 Daiichi Sankyo Recent Developments
11.6 Armatheon
11.6.1 Armatheon Company Information
11.6.2 Armatheon Overview
11.6.3 Armatheon Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Armatheon Oral Anticoagulants Products and Services
11.6.5 Armatheon Oral Anticoagulants SWOT Analysis
11.6.6 Armatheon Recent Developments
11.7 Aspen
11.7.1 Aspen Company Information
11.7.2 Aspen Overview
11.7.3 Aspen Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Aspen Oral Anticoagulants Products and Services
11.7.5 Aspen Oral Anticoagulants SWOT Analysis
11.7.6 Aspen Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 AstraZeneca Oral Anticoagulants Products and Services
11.8.5 AstraZeneca Oral Anticoagulants SWOT Analysis
11.8.6 AstraZeneca Recent Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Overview
11.9.3 Bayer Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Bayer Oral Anticoagulants Products and Services
11.9.5 Bayer Oral Anticoagulants SWOT Analysis
11.9.6 Bayer Recent Developments
11.10 Cellceutix
11.10.1 Cellceutix Company Information
11.10.2 Cellceutix Overview
11.10.3 Cellceutix Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Cellceutix Oral Anticoagulants Products and Services
11.10.5 Cellceutix Oral Anticoagulants SWOT Analysis
11.10.6 Cellceutix Recent Developments
11.11 Cosmo Pharmaceuticals
11.11.1 Cosmo Pharmaceuticals Company Information
11.11.2 Cosmo Pharmaceuticals Overview
11.11.3 Cosmo Pharmaceuticals Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Cosmo Pharmaceuticals Oral Anticoagulants Products and Services
11.11.5 Cosmo Pharmaceuticals Recent Developments
11.12 CSL Behring
11.12.1 CSL Behring Company Information
11.12.2 CSL Behring Overview
11.12.3 CSL Behring Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 CSL Behring Oral Anticoagulants Products and Services
11.12.5 CSL Behring Recent Developments
11.13 Eisai
11.13.1 Eisai Company Information
11.13.2 Eisai Overview
11.13.3 Eisai Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Eisai Oral Anticoagulants Products and Services
11.13.5 Eisai Recent Developments
11.14 GSK
11.14.1 GSK Company Information
11.14.2 GSK Overview
11.14.3 GSK Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.14.4 GSK Oral Anticoagulants Products and Services
11.14.5 GSK Recent Developments
11.15 Marathon Pharmaceuticals
11.15.1 Marathon Pharmaceuticals Company Information
11.15.2 Marathon Pharmaceuticals Overview
11.15.3 Marathon Pharmaceuticals Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.15.4 Marathon Pharmaceuticals Oral Anticoagulants Products and Services
11.15.5 Marathon Pharmaceuticals Recent Developments
11.16 Ockham Biotech
11.16.1 Ockham Biotech Company Information
11.16.2 Ockham Biotech Overview
11.16.3 Ockham Biotech Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.16.4 Ockham Biotech Oral Anticoagulants Products and Services
11.16.5 Ockham Biotech Recent Developments
11.17 Perosphere
11.17.1 Perosphere Company Information
11.17.2 Perosphere Overview
11.17.3 Perosphere Oral Anticoagulants Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.17.4 Perosphere Oral Anticoagulants Products and Services
11.17.5 Perosphere Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Oral Anticoagulants Value Chain Analysis
12.2 Oral Anticoagulants Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Anticoagulants Production Mode & Process
12.4 Oral Anticoagulants Sales and Marketing
12.4.1 Oral Anticoagulants Sales Channels
12.4.2 Oral Anticoagulants Distributors
12.5 Oral Anticoagulants Customers
13 Market Dynamics
13.1 Oral Anticoagulants Industry Trends
13.2 Oral Anticoagulants Market Drivers
13.3 Oral Anticoagulants Market Challenges
13.4 Oral Anticoagulants Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oral Anticoagulants Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Direct Thrombin Inhibitors
Table 3. Major Manufacturers of Direct Factor Xa Inhibitors
Table 4. Global Oral Anticoagulants Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Oral Anticoagulants Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Oral Anticoagulants Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Oral Anticoagulants Revenue Market Share by Region (2018-2023)
Table 8. Global Oral Anticoagulants Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Oral Anticoagulants Revenue Market Share by Region (2024-2034)
Table 10. Global Oral Anticoagulants Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 11. Global Oral Anticoagulants Sales by Region (2018-2023) & (K Units)
Table 12. Global Oral Anticoagulants Sales Market Share by Region (2018-2023)
Table 13. Global Oral Anticoagulants Sales by Region (2024-2034) & (K Units)
Table 14. Global Oral Anticoagulants Sales Market Share by Region (2024-2034)
Table 15. Global Oral Anticoagulants Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 16. Global Oral Anticoagulants Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Oral Anticoagulants Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Oral Anticoagulants Revenue Share by Manufacturers (2018-2023)
Table 19. Global Oral Anticoagulants Price by Manufacturers 2018-2023 (USD/Unit)
Table 20. Global Key Players of Oral Anticoagulants, Industry Ranking, 2021 VS 2024
Table 21. Global Oral Anticoagulants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Oral Anticoagulants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Anticoagulants as of 2024)
Table 23. Global Key Manufacturers of Oral Anticoagulants, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Oral Anticoagulants, Product Offered and Application
Table 25. Global Key Manufacturers of Oral Anticoagulants, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oral Anticoagulants Sales Quantity by Type (2018-2023) & (K Units)
Table 28. Global Oral Anticoagulants Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Oral Anticoagulants Sales Quantity Share by Type (2018-2023)
Table 30. Global Oral Anticoagulants Sales Quantity Share by Type (2024-2034)
Table 31. Global Oral Anticoagulants Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Oral Anticoagulants Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Oral Anticoagulants Revenue Share by Type (2018-2023)
Table 34. Global Oral Anticoagulants Revenue Share by Type (2024-2034)
Table 35. Oral Anticoagulants Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Oral Anticoagulants Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Oral Anticoagulants Sales Quantity by Application (2018-2023) & (K Units)
Table 38. Global Oral Anticoagulants Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Oral Anticoagulants Sales Quantity Share by Application (2018-2023)
Table 40. Global Oral Anticoagulants Sales Quantity Share by Application (2024-2034)
Table 41. Global Oral Anticoagulants Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Oral Anticoagulants Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Oral Anticoagulants Revenue Share by Application (2018-2023)
Table 44. Global Oral Anticoagulants Revenue Share by Application (2024-2034)
Table 45. Oral Anticoagulants Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Oral Anticoagulants Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Oral Anticoagulants Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Oral Anticoagulants Sales Quantity by Company (2018-2023) & (K Units)
Table 49. North America Oral Anticoagulants Sales Quantity by Type (2018-2023) & (K Units)
Table 50. North America Oral Anticoagulants Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Oral Anticoagulants Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Oral Anticoagulants Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Oral Anticoagulants Sales Quantity by Application (2018-2023) & (K Units)
Table 54. North America Oral Anticoagulants Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Oral Anticoagulants Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Oral Anticoagulants Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Oral Anticoagulants Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 58. North America Oral Anticoagulants Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Oral Anticoagulants Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Oral Anticoagulants Sales Quantity by Country (2018-2023) & (K Units)
Table 61. North America Oral Anticoagulants Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Oral Anticoagulants Sales Quantity by Company (2018-2023) & (K Units)
Table 63. Europe Oral Anticoagulants Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Oral Anticoagulants Sales Quantity by Type (2018-2023) & (K Units)
Table 65. Europe Oral Anticoagulants Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Oral Anticoagulants Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Oral Anticoagulants Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Oral Anticoagulants Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Europe Oral Anticoagulants Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Oral Anticoagulants Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Oral Anticoagulants Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Oral Anticoagulants Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Oral Anticoagulants Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Oral Anticoagulants Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Oral Anticoagulants Sales Quantity by Country (2018-2023) & (K Units)
Table 76. Europe Oral Anticoagulants Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Oral Anticoagulants Sales Quantity by Company (2018-2023) & (K Units)
Table 78. China Oral Anticoagulants Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Oral Anticoagulants Sales Quantity by Type (2018-2023) & (K Units)
Table 80. China Oral Anticoagulants Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Oral Anticoagulants Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Oral Anticoagulants Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Oral Anticoagulants Sales Quantity by Application (2018-2023) & (K Units)
Table 84. China Oral Anticoagulants Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Oral Anticoagulants Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Oral Anticoagulants Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Oral Anticoagulants Sales Quantity by Company (2018-2023) & (K Units)
Table 88. APAC Oral Anticoagulants Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Oral Anticoagulants Sales Quantity by Type (2018-2023) & (K Units)
Table 90. APAC Oral Anticoagulants Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Oral Anticoagulants Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Oral Anticoagulants Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Oral Anticoagulants Sales Quantity by Application (2018-2023) & (K Units)
Table 94. APAC Oral Anticoagulants Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Oral Anticoagulants Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Oral Anticoagulants Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Oral Anticoagulants Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 98. APAC Oral Anticoagulants Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Oral Anticoagulants Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Oral Anticoagulants Sales Quantity by Region (2018-2023) & (K Units)
Table 101. APAC Oral Anticoagulants Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity by Company (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Oral Anticoagulants Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity by Type (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Oral Anticoagulants Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Oral Anticoagulants Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Oral Anticoagulants Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Oral Anticoagulants Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Oral Anticoagulants Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Oral Anticoagulants Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Oral Anticoagulants Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity by Country (2018-2023) & (K Units)
Table 116. Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Johnson & Johnson Company Information
Table 118. Johnson & Johnson Description and Overview
Table 119. Johnson & Johnson Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 120. Johnson & Johnson Oral Anticoagulants Product and Services
Table 121. Johnson & Johnson Oral Anticoagulants SWOT Analysis
Table 122. Johnson & Johnson Recent Developments
Table 123. Bristol-Myers Squibb Company Information
Table 124. Bristol-Myers Squibb Description and Overview
Table 125. Bristol-Myers Squibb Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 126. Bristol-Myers Squibb Oral Anticoagulants Product and Services
Table 127. Bristol-Myers Squibb Oral Anticoagulants SWOT Analysis
Table 128. Bristol-Myers Squibb Recent Developments
Table 129. Boehringer Ingelheim Company Information
Table 130. Boehringer Ingelheim Description and Overview
Table 131. Boehringer Ingelheim Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 132. Boehringer Ingelheim Oral Anticoagulants Product and Services
Table 133. Boehringer Ingelheim Oral Anticoagulants SWOT Analysis
Table 134. Boehringer Ingelheim Recent Developments
Table 135. Sanofi Company Information
Table 136. Sanofi Description and Overview
Table 137. Sanofi Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 138. Sanofi Oral Anticoagulants Product and Services
Table 139. Sanofi Oral Anticoagulants SWOT Analysis
Table 140. Sanofi Recent Developments
Table 141. Daiichi Sankyo Company Information
Table 142. Daiichi Sankyo Description and Overview
Table 143. Daiichi Sankyo Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 144. Daiichi Sankyo Oral Anticoagulants Product and Services
Table 145. Daiichi Sankyo Oral Anticoagulants SWOT Analysis
Table 146. Daiichi Sankyo Recent Developments
Table 147. Armatheon Company Information
Table 148. Armatheon Description and Overview
Table 149. Armatheon Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 150. Armatheon Oral Anticoagulants Product and Services
Table 151. Armatheon Oral Anticoagulants SWOT Analysis
Table 152. Armatheon Recent Developments
Table 153. Aspen Company Information
Table 154. Aspen Description and Overview
Table 155. Aspen Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 156. Aspen Oral Anticoagulants Product and Services
Table 157. Aspen Oral Anticoagulants SWOT Analysis
Table 158. Aspen Recent Developments
Table 159. AstraZeneca Company Information
Table 160. AstraZeneca Description and Overview
Table 161. AstraZeneca Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 162. AstraZeneca Oral Anticoagulants Product and Services
Table 163. AstraZeneca Oral Anticoagulants SWOT Analysis
Table 164. AstraZeneca Recent Developments
Table 165. Bayer Company Information
Table 166. Bayer Description and Overview
Table 167. Bayer Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 168. Bayer Oral Anticoagulants Product and Services
Table 169. Bayer Oral Anticoagulants SWOT Analysis
Table 170. Bayer Recent Developments
Table 171. Cellceutix Company Information
Table 172. Cellceutix Description and Overview
Table 173. Cellceutix Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 174. Cellceutix Oral Anticoagulants Product and Services
Table 175. Cellceutix Oral Anticoagulants SWOT Analysis
Table 176. Cellceutix Recent Developments
Table 177. Cosmo Pharmaceuticals Company Information
Table 178. Cosmo Pharmaceuticals Description and Overview
Table 179. Cosmo Pharmaceuticals Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 180. Cosmo Pharmaceuticals Oral Anticoagulants Product and Services
Table 181. Cosmo Pharmaceuticals Recent Developments
Table 182. CSL Behring Company Information
Table 183. CSL Behring Description and Overview
Table 184. CSL Behring Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 185. CSL Behring Oral Anticoagulants Product and Services
Table 186. CSL Behring Recent Developments
Table 187. Eisai Company Information
Table 188. Eisai Description and Overview
Table 189. Eisai Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 190. Eisai Oral Anticoagulants Product and Services
Table 191. Eisai Recent Developments
Table 192. GSK Company Information
Table 193. GSK Description and Overview
Table 194. GSK Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 195. GSK Oral Anticoagulants Product and Services
Table 196. GSK Recent Developments
Table 197. Marathon Pharmaceuticals Company Information
Table 198. Marathon Pharmaceuticals Description and Overview
Table 199. Marathon Pharmaceuticals Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 200. Marathon Pharmaceuticals Oral Anticoagulants Product and Services
Table 201. Marathon Pharmaceuticals Recent Developments
Table 202. Ockham Biotech Company Information
Table 203. Ockham Biotech Description and Overview
Table 204. Ockham Biotech Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 205. Ockham Biotech Oral Anticoagulants Product and Services
Table 206. Ockham Biotech Recent Developments
Table 207. Perosphere Company Information
Table 208. Perosphere Description and Overview
Table 209. Perosphere Oral Anticoagulants Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 210. Perosphere Oral Anticoagulants Product and Services
Table 211. Perosphere Recent Developments
Table 212. Key Raw Materials Lists
Table 213. Raw Materials Key Suppliers Lists
Table 214. Oral Anticoagulants Distributors List
Table 215. Oral Anticoagulants Customers List
Table 216. Oral Anticoagulants Market Trends
Table 217. Oral Anticoagulants Market Drivers
Table 218. Oral Anticoagulants Market Challenges
Table 219. Oral Anticoagulants Market Restraints
Table 220. Research Programs/Design for This Report
Table 221. Key Data Information from Secondary Sources
Table 222. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Anticoagulants Product Picture
Figure 2. Global Oral Anticoagulants Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Oral Anticoagulants Market Share by Type in 2024 & 2034
Figure 4. Direct Thrombin Inhibitors Product Picture
Figure 5. Direct Factor Xa Inhibitors Product Picture
Figure 6. Global Oral Anticoagulants Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Oral Anticoagulants Market Share by Application in 2024 & 2034
Figure 8. Deep Vein Thrombosis (DVT)
Figure 9. Pulmonary Embolism
Figure 10. Acute Coronary Syndrome
Figure 11. Hemodialysis
Figure 12. Others
Figure 13. Oral Anticoagulants Report Years Considered
Figure 14. Global Oral Anticoagulants Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Oral Anticoagulants Revenue 2018-2034 (US$ Million)
Figure 16. Global Oral Anticoagulants Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 17. Global Oral Anticoagulants Sales Quantity 2018-2034 (K Units)
Figure 18. Global Oral Anticoagulants Sales Quantity Market Share by Region (2018-2023)
Figure 19. Global Oral Anticoagulants Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Oral Anticoagulants Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. North America Oral Anticoagulants Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Oral Anticoagulants Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. Europe Oral Anticoagulants Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Oral Anticoagulants Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. China Oral Anticoagulants Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Oral Anticoagulants Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. APAC Oral Anticoagulants Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity YoY (2018-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Oral Anticoagulants Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Oral Anticoagulants Sales Quantity in 2024
Figure 31. The Top 10 and Top 5 Players Market Share by Oral Anticoagulants Revenue in 2024
Figure 32. Oral Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 33. Global Oral Anticoagulants Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Oral Anticoagulants Revenue Market Share by Type (2018-2034)
Figure 35. Global Oral Anticoagulants Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Oral Anticoagulants Revenue Market Share by Application (2018-2034)
Figure 37. North America Oral Anticoagulants Revenue Market Share by Company in 2024
Figure 38. North America Oral Anticoagulants Sales Quantity Market Share by Company in 2024
Figure 39. North America Oral Anticoagulants Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Oral Anticoagulants Revenue Market Share by Type (2018-2034)
Figure 41. North America Oral Anticoagulants Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Oral Anticoagulants Revenue Market Share by Application (2018-2034)
Figure 43. North America Oral Anticoagulants Revenue Share by Country (2018-2034)
Figure 44. North America Oral Anticoagulants Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Oral Anticoagulants Sales Quantity Market Share by Company in 2024
Figure 48. Europe Oral Anticoagulants Revenue Market Share by Company in 2024
Figure 49. Europe Oral Anticoagulants Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Oral Anticoagulants Revenue Market Share by Type (2018-2034)
Figure 51. Europe Oral Anticoagulants Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Oral Anticoagulants Revenue Market Share by Application (2018-2034)
Figure 53. Europe Oral Anticoagulants Revenue Share by Country (2018-2034)
Figure 54. Europe Oral Anticoagulants Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 56. France Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 60. China Oral Anticoagulants Sales Quantity Market Share by Company in 2024
Figure 61. China Oral Anticoagulants Revenue Market Share by Company in 2024
Figure 62. China Oral Anticoagulants Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Oral Anticoagulants Revenue Market Share by Type (2018-2034)
Figure 64. China Oral Anticoagulants Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Oral Anticoagulants Revenue Market Share by Application (2018-2034)
Figure 66. APAC Oral Anticoagulants Sales Quantity Market Share by Company in 2024
Figure 67. APAC Oral Anticoagulants Revenue Market Share by Company in 2024
Figure 68. APAC Oral Anticoagulants Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Oral Anticoagulants Revenue Market Share by Type (2018-2034)
Figure 70. APAC Oral Anticoagulants Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Oral Anticoagulants Revenue Market Share by Application (2018-2034)
Figure 72. APAC Oral Anticoagulants Revenue Share by Region (2018-2034)
Figure 73. APAC Oral Anticoagulants Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 78. India Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Oral Anticoagulants Revenue Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Oral Anticoagulants Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Oral Anticoagulants Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Oral Anticoagulants Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Oral Anticoagulants Revenue Share by Country (2018-2034)
Figure 87. Brazil Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Oral Anticoagulants Revenue (2018-2034) & (US$ Million)
Figure 92. Oral Anticoagulants Value Chain
Figure 93. Oral Anticoagulants Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed